Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04873037 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT04873037 · ClinicalTrials.gov record · last posted 2026-07-09

BTL Emsella Chair Versus Sham for the Treatment of Overactive Bladder

Study acronym: EmsellaOAB
StatusRecruiting
PhaseNot applicable
Started2021-11-22
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
The purpose of this clinical trial is to compare the Emsella Chair therapy to Sham and to determine whether electromagnetic technology is effective in the treatment of overactive bladder (OAB). Currently there are no other studies utilizing the Emsella Chair for the treatment of OAB. Eligible subjects will receive 2 treatments per week for a total of 4 weeks.

Amendment record 13 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 13 times since 2021-04-29; most recent amendment 2026-07-07. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2021-07-01
Status change Not Yet Recruiting→Recruitingv2
Trial Details
NCT Number NCT04873037
Lead Sponsor Corewell Health East
Conditions Overactive Bladder Syndrome, Overactive Bladder, Urinary Frequency, Urinary Urgency
Enrollment 166 participants
Start Date 2021-11-22
Primary Completion 2028-06 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-09